 | • レポートコード：QY2207C3765 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の糖尿病検査プログラムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糖尿病検査プログラムの世界市場のxxx％を占める「機器」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の糖尿病検査プログラムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの糖尿病検査プログラム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの糖尿病検査プログラム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 糖尿病検査プログラムのグローバル主要メーカーには、InSphero AG、Abbott Laboratories、American Laboratory Products Company (ALPCO)、Beckmann Coulter Inc.、Bio-Rad Laboratories Inc.、Ortho Clinical Diagnostics Inc.、F. Hoffmann-la Roche Ltd、Siemens AG、PTS Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 糖尿病検査プログラム市場は、種類と用途によって区分されます。世界の糖尿病検査プログラム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 機器、検査キット、試薬 【用途別セグメント】 病院、専門クリニック、診断センター、在宅医療施設、学術研究所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 糖尿病検査プログラム製品概要 - 種類別市場（機器、検査キット、試薬） - 用途別市場（病院、専門クリニック、診断センター、在宅医療施設、学術研究所） - 調査の目的 ・エグゼクティブサマリー - 世界の糖尿病検査プログラム販売量予測2017-2028 - 世界の糖尿病検査プログラム売上予測2017-2028 - 糖尿病検査プログラムの地域別販売量 - 糖尿病検査プログラムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別糖尿病検査プログラム販売量 - 主要メーカー別糖尿病検査プログラム売上 - 主要メーカー別糖尿病検査プログラム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（機器、検査キット、試薬） - 糖尿病検査プログラムの種類別販売量 - 糖尿病検査プログラムの種類別売上 - 糖尿病検査プログラムの種類別価格 ・用途別市場規模（病院、専門クリニック、診断センター、在宅医療施設、学術研究所） - 糖尿病検査プログラムの用途別販売量 - 糖尿病検査プログラムの用途別売上 - 糖尿病検査プログラムの用途別価格 ・北米市場 - 北米の糖尿病検査プログラム市場規模（種類別、用途別） - 主要国別の糖尿病検査プログラム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの糖尿病検査プログラム市場規模（種類別、用途別） - 主要国別の糖尿病検査プログラム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の糖尿病検査プログラム市場規模（種類別、用途別） - 主要国別の糖尿病検査プログラム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の糖尿病検査プログラム市場規模（種類別、用途別） - 主要国別の糖尿病検査プログラム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの糖尿病検査プログラム市場規模（種類別、用途別） - 主要国別の糖尿病検査プログラム市場規模（トルコ、サウジアラビア） ・企業情報 InSphero AG、Abbott Laboratories、American Laboratory Products Company (ALPCO)、Beckmann Coulter Inc.、Bio-Rad Laboratories Inc.、Ortho Clinical Diagnostics Inc.、F. Hoffmann-la Roche Ltd、Siemens AG、PTS Diagnostics ・産業チェーン及び販売チャネル分析 - 糖尿病検査プログラムの産業チェーン分析 - 糖尿病検査プログラムの原材料 - 糖尿病検査プログラムの生産プロセス - 糖尿病検査プログラムの販売及びマーケティング - 糖尿病検査プログラムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 糖尿病検査プログラムの産業動向 - 糖尿病検査プログラムのマーケットドライバー - 糖尿病検査プログラムの課題 - 糖尿病検査プログラムの阻害要因 ・主な調査結果 |
A program for detecting diabetes, generally including fasting plasma glucose test, oral glucose tolerance test, etc.
Market Analysis and Insights: Global Diabetes Testing Program Market
The global Diabetes Testing Program market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Instruments accounting for % of the Diabetes Testing Program global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Diabetes Testing Program market size is valued at US$ million in 2021, while the North America and Europe Diabetes Testing Program are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diabetes Testing Program landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Testing Program market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Testing Program market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Testing Program market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Testing Program market.
Global Diabetes Testing Program Scope and Market Size
Diabetes Testing Program market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Diabetes Testing Program market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Instruments
Testing Kits
Reagent
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Home Care Settings
Academic Research Institutes
By Company
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Instruments
1.2.3 Testing Kits
1.2.4 Reagent
1.3 Market by Application
1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Home Care Settings
1.3.6 Academic Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Testing Program Market Perspective (2017-2028)
2.2 Diabetes Testing Program Growth Trends by Region
2.2.1 Diabetes Testing Program Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diabetes Testing Program Historic Market Size by Region (2017-2022)
2.2.3 Diabetes Testing Program Forecasted Market Size by Region (2023-2028)
2.3 Diabetes Testing Program Market Dynamics
2.3.1 Diabetes Testing Program Industry Trends
2.3.2 Diabetes Testing Program Market Drivers
2.3.3 Diabetes Testing Program Market Challenges
2.3.4 Diabetes Testing Program Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Testing Program Players by Revenue
3.1.1 Global Top Diabetes Testing Program Players by Revenue (2017-2022)
3.1.2 Global Diabetes Testing Program Revenue Market Share by Players (2017-2022)
3.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Testing Program Revenue
3.4 Global Diabetes Testing Program Market Concentration Ratio
3.4.1 Global Diabetes Testing Program Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2021
3.5 Diabetes Testing Program Key Players Head office and Area Served
3.6 Key Players Diabetes Testing Program Product Solution and Service
3.7 Date of Enter into Diabetes Testing Program Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Testing Program Breakdown Data by Type
4.1 Global Diabetes Testing Program Historic Market Size by Type (2017-2022)
4.2 Global Diabetes Testing Program Forecasted Market Size by Type (2023-2028)
5 Diabetes Testing Program Breakdown Data by Application
5.1 Global Diabetes Testing Program Historic Market Size by Application (2017-2022)
5.2 Global Diabetes Testing Program Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diabetes Testing Program Market Size (2017-2028)
6.2 North America Diabetes Testing Program Market Size by Type
6.2.1 North America Diabetes Testing Program Market Size by Type (2017-2022)
6.2.2 North America Diabetes Testing Program Market Size by Type (2023-2028)
6.2.3 North America Diabetes Testing Program Market Share by Type (2017-2028)
6.3 North America Diabetes Testing Program Market Size by Application
6.3.1 North America Diabetes Testing Program Market Size by Application (2017-2022)
6.3.2 North America Diabetes Testing Program Market Size by Application (2023-2028)
6.3.3 North America Diabetes Testing Program Market Share by Application (2017-2028)
6.4 North America Diabetes Testing Program Market Size by Country
6.4.1 North America Diabetes Testing Program Market Size by Country (2017-2022)
6.4.2 North America Diabetes Testing Program Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Testing Program Market Size (2017-2028)
7.2 Europe Diabetes Testing Program Market Size by Type
7.2.1 Europe Diabetes Testing Program Market Size by Type (2017-2022)
7.2.2 Europe Diabetes Testing Program Market Size by Type (2023-2028)
7.2.3 Europe Diabetes Testing Program Market Share by Type (2017-2028)
7.3 Europe Diabetes Testing Program Market Size by Application
7.3.1 Europe Diabetes Testing Program Market Size by Application (2017-2022)
7.3.2 Europe Diabetes Testing Program Market Size by Application (2023-2028)
7.3.3 Europe Diabetes Testing Program Market Share by Application (2017-2028)
7.4 Europe Diabetes Testing Program Market Size by Country
7.4.1 Europe Diabetes Testing Program Market Size by Country (2017-2022)
7.4.2 Europe Diabetes Testing Program Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Testing Program Market Size (2017-2028)
8.2 Asia-Pacific Diabetes Testing Program Market Size by Type
8.2.1 Asia-Pacific Diabetes Testing Program Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diabetes Testing Program Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diabetes Testing Program Market Share by Type (2017-2028)
8.3 Asia-Pacific Diabetes Testing Program Market Size by Application
8.3.1 Asia-Pacific Diabetes Testing Program Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Diabetes Testing Program Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Diabetes Testing Program Market Share by Application (2017-2028)
8.4 Asia-Pacific Diabetes Testing Program Market Size by Region
8.4.1 Asia-Pacific Diabetes Testing Program Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diabetes Testing Program Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Testing Program Market Size (2017-2028)
9.2 Latin America Diabetes Testing Program Market Size by Type
9.2.1 Latin America Diabetes Testing Program Market Size by Type (2017-2022)
9.2.2 Latin America Diabetes Testing Program Market Size by Type (2023-2028)
9.2.3 Latin America Diabetes Testing Program Market Share by Type (2017-2028)
9.3 Latin America Diabetes Testing Program Market Size by Application
9.3.1 Latin America Diabetes Testing Program Market Size by Application (2017-2022)
9.3.2 Latin America Diabetes Testing Program Market Size by Application (2023-2028)
9.3.3 Latin America Diabetes Testing Program Market Share by Application (2017-2028)
9.4 Latin America Diabetes Testing Program Market Size by Country
9.4.1 Latin America Diabetes Testing Program Market Size by Country (2017-2022)
9.4.2 Latin America Diabetes Testing Program Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Testing Program Market Size (2017-2028)
10.2 Middle East & Africa Diabetes Testing Program Market Size by Type
10.2.1 Middle East & Africa Diabetes Testing Program Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diabetes Testing Program Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diabetes Testing Program Market Share by Type (2017-2028)
10.3 Middle East & Africa Diabetes Testing Program Market Size by Application
10.3.1 Middle East & Africa Diabetes Testing Program Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Diabetes Testing Program Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Diabetes Testing Program Market Share by Application (2017-2028)
10.4 Middle East & Africa Diabetes Testing Program Market Size by Country
10.4.1 Middle East & Africa Diabetes Testing Program Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diabetes Testing Program Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 InSphero AG
11.1.1 InSphero AG Company Details
11.1.2 InSphero AG Business Overview
11.1.3 InSphero AG Diabetes Testing Program Introduction
11.1.4 InSphero AG Revenue in Diabetes Testing Program Business (2017-2022)
11.1.5 InSphero AG Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Diabetes Testing Program Introduction
11.2.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 American Laboratory Products Company (ALPCO)
11.3.1 American Laboratory Products Company (ALPCO) Company Details
11.3.2 American Laboratory Products Company (ALPCO) Business Overview
11.3.3 American Laboratory Products Company (ALPCO) Diabetes Testing Program Introduction
11.3.4 American Laboratory Products Company (ALPCO) Revenue in Diabetes Testing Program Business (2017-2022)
11.3.5 American Laboratory Products Company (ALPCO) Recent Developments
11.4 Beckmann Coulter Inc.
11.4.1 Beckmann Coulter Inc. Company Details
11.4.2 Beckmann Coulter Inc. Business Overview
11.4.3 Beckmann Coulter Inc. Diabetes Testing Program Introduction
11.4.4 Beckmann Coulter Inc. Revenue in Diabetes Testing Program Business (2017-2022)
11.4.5 Beckmann Coulter Inc. Recent Developments
11.5 Bio-Rad Laboratories Inc.
11.5.1 Bio-Rad Laboratories Inc. Company Details
11.5.2 Bio-Rad Laboratories Inc. Business Overview
11.5.3 Bio-Rad Laboratories Inc. Diabetes Testing Program Introduction
11.5.4 Bio-Rad Laboratories Inc. Revenue in Diabetes Testing Program Business (2017-2022)
11.5.5 Bio-Rad Laboratories Inc. Recent Developments
11.6 Ortho Clinical Diagnostics Inc.
11.6.1 Ortho Clinical Diagnostics Inc. Company Details
11.6.2 Ortho Clinical Diagnostics Inc. Business Overview
11.6.3 Ortho Clinical Diagnostics Inc. Diabetes Testing Program Introduction
11.6.4 Ortho Clinical Diagnostics Inc. Revenue in Diabetes Testing Program Business (2017-2022)
11.6.5 Ortho Clinical Diagnostics Inc. Recent Developments
11.7 F. Hoffmann-la Roche Ltd
11.7.1 F. Hoffmann-la Roche Ltd Company Details
11.7.2 F. Hoffmann-la Roche Ltd Business Overview
11.7.3 F. Hoffmann-la Roche Ltd Diabetes Testing Program Introduction
11.7.4 F. Hoffmann-la Roche Ltd Revenue in Diabetes Testing Program Business (2017-2022)
11.7.5 F. Hoffmann-la Roche Ltd Recent Developments
11.8 Siemens AG
11.8.1 Siemens AG Company Details
11.8.2 Siemens AG Business Overview
11.8.3 Siemens AG Diabetes Testing Program Introduction
11.8.4 Siemens AG Revenue in Diabetes Testing Program Business (2017-2022)
11.8.5 Siemens AG Recent Developments
11.9 PTS Diagnostics
11.9.1 PTS Diagnostics Company Details
11.9.2 PTS Diagnostics Business Overview
11.9.3 PTS Diagnostics Diabetes Testing Program Introduction
11.9.4 PTS Diagnostics Revenue in Diabetes Testing Program Business (2017-2022)
11.9.5 PTS Diagnostics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer